Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Earnings for Outset Medical, Inc. (OM)
Earnings in 2023 (TTM): $-172,274,000
According to Outset Medical, Inc.'s latest financial reports the company's current earnings (TTM) are $-172,274,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Outset Medical, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-172,274,000 | $-172,797,000 |
| 2022 | $-162,661,000 | $-162,956,000 |
| 2021 | $-131,736,000 | $-131,935,000 |
| 2020 | $-121,492,000 | $-120,698,000 |
| 2019 | $-68,279,000 | $-68,299,000 |
| 2018 | $-49,755,000 | $-49,780,000 |